| Project | Period | Location(s) | N | Primary outcome | Study name | Principal Investigator | Institute |
|---|---|---|---|---|---|---|---|
| CORESMA | -- | 2 locations in Germany, Nepal | 9000 | Seroprevalence of SARS-Cov-2 antibodies in Nepal and Germany | Covid-19 Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research | Gérard Krause | Helmholtz HZI |